What is the market doing?
What the tape says about REGN
Regeneron Pharmaceuticals is +48% over the past year while the S&P 500 is +23%: 25 points ahead of the market.
+48%
1-year return · S&P 500 +23%
- vs 200-day average
- +13%
vs 200-day average · a clear uptrend
- RSI (14)
- 65
RSI (14) · neutral
- Below its 52-week high
- −3.1%
Below its 52-week high
Details›
- Last close2026-08-26
- $814.96
- 1 monthS&P 500 +3.7%
- +25%
- 1 yearS&P 500 +23%
- +48%
- 5 yearsS&P 500 +87%
- +43%
- vs 50-day average$696.09
- +17%
- 52-week high
- $841.24
- 52-week low
- $542.96
- Annualised volatility
- 37%
| Year | Return |
|---|---|
| 2026 (year to date) | +5.9% |
| 2025 | +9.0% |
| 2024 | −19% |
| 2023 | +22% |
| 2022 | +14% |
| 2021 | +31% |
| 2020 | +29% |
| 2019 | +0.53% |
| 2018 | −0.65% |
| 2017 | +2.4% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 4 of 10 | +0.40% |
| Feb | 10 | 8 of 10 | +2.7% |
| Mar | 10 | 6 of 10 | +3.2% |
| Apr | 10 | 3 of 10 | −4.8% |
| May | 10 | 5 of 10 | −0.24% |
| Jun | 10 | 8 of 10 | +4.1% |
| Jul | 11 | 9 of 11 | +4.5% |
| Aug | 11 | 7 of 11 | +5.4% |
| Sep | 10 | 2 of 10 | −2.9% |
| Oct | 10 | 4 of 10 | −2.8% |
| Nov | 10 | 6 of 10 | +3.8% |
| Dec | 10 | 4 of 10 | −0.61% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.